Allice drugs have state of the art R&D facility in India to develop niche complex Biotechnology products. The research team comprises of senior scientists who have rich experience in the field of Biotechnology.The laboratory is equipped with facility for Isolation of strain, Mutation & Passive Selection of microbial strains and strain improvement, laboratory fermenters and pilot plant facility for scale-up of fermentation process.
Allice drugs plans developing six core technologies by utilizing its technologies accumulated through a broad range of research activities over many years. The six core technologies are catalyst design, high-precision processing, design of functional organic chemicals and polymers, design of functional inorganic materials, device design, and analysis of bio-mechanisms. Sumitomo Chemical’s Creative Hybrid Chemistry forms the basis of its R&D strategy.
Formulation studies assess the bioavailability of a drug based on its particle size, pH, polymorphism, and solubility; inactive ingredients must be added in such a way that the formulation of each dosage is consistent so there is no variation from one tablet or capsule to the next. Dosages must also have a standardized
appearance and a tolerable taste, and oral medications must be fully broken down in the digestive tract.